跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
謝 宗翰
副研究員
,
聯合人體生物資料庫
成員
,
臺北醫學大學癌症轉譯研究中心
https://orcid.org/0000-0002-2268-9246
電子郵件
thhsieh
tmu.edu
tw
No. 250 Wu-Xing Street, Taipei 11031
h-index
759
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2024
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(53)
類似的個人檔案
(6)
指紋
查看啟用 Tsung-Han Hsieh 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Neoplasm
100%
Cancer Cell
32%
RNA Sequence
31%
Metastatic Carcinoma
27%
Pediatrics
26%
Atypical Teratoid Rhabdoid Tumor
26%
Gene Rearrangement
24%
Sarcoma
23%
Malignant Neoplasm
23%
Diagnosis
19%
Upregulation
19%
Ganglioglioma
19%
Fluorescence in Situ Hybridization
18%
down Regulation
18%
Autophagy
17%
Programmed Cell Death
17%
Central Nervous System
15%
Tumor Cell
15%
microRNA
15%
Immunohistochemistry
15%
Hepatocellular Carcinoma
15%
Medulloblastoma
15%
Exome Sequencing
14%
Fusion Gene
14%
Radiation Therapy
13%
Cell Proliferation
13%
Xenograft
12%
Spindle Cell
12%
Bladder Cancer
11%
DNA Damage Response
11%
DNA Methylation
11%
Immunoreactivity
11%
Cancer
11%
Uterus Sarcoma
10%
Cas9
10%
Clustered Regularly Interspaced Short Palindromic Repeat
10%
Cisplatin
10%
Personalized Medicine
10%
Non Small Cell Lung Cancer
10%
Tumor Suppressor Protein
10%
Chemotherapy
9%
Polymerase Chain Reaction
9%
Disease
9%
Cell Migration
9%
Mucin 4
9%
Myoepithelioma
9%
Carcinoma
9%
Oxaliplatin
8%
microRNA 214
8%
Pancreas Adenocarcinoma
8%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
39%
RNA Sequence
36%
Autophagy
26%
MicroRNA
23%
Fluorescence in Situ Hybridization
21%
down Regulation
20%
Transcriptome
19%
Programmed Cell Death
17%
Cell Death
16%
Cell Proliferation
16%
RNA Gene
14%
Tumor Suppressor Protein
13%
RRM2
13%
Survival Rate
13%
Genetics
13%
Messenger RNA
12%
DNA Damage Response
11%
Embryonic Stem Cell
11%
DNA Methylation
11%
Messenger RNA
11%
CRISPR/Cas9
10%
Cisplatin
10%
RNA
9%
FGF1
9%
Fibroblast Growth Factor 23
9%
Upregulation
9%
Human Immunodeficiency Virus
8%
MUC4
8%
Arginine
8%
COL1A2
8%
Genetic Predisposition
8%
Argininosuccinate Synthetase 1
8%
Gene Rearrangement
8%
YAP1
8%
KMT2A
8%
Infrared Radiation
8%
Protein Kinase R
8%
Non-Coding RNA
8%
Ligase
8%
TIA1
8%
Adenosine Monophosphate
8%
Synthase
8%
N6-Methyladenosine
8%
Cyclic Guanosine Monophosphate
8%
LIM Domain
8%
Exome Sequencing
8%
Gene Expression
8%
Immunoreactivity
7%
Antineoplastic Activity
6%
Signal Transduction
6%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
32%
Bladder Cancer
29%
Neoplasm
25%
microRNA
23%
Atypical Teratoid Rhabdoid Tumor
17%
Abemaciclib
17%
Tumor Suppressor Protein
14%
Survival Rate
12%
RNA-Sequencing
11%
Cardiovascular Disease
11%
Cisplatin
11%
Non Small Cell Lung Cancer
10%
Organic Cation Transporter 2
8%
Lung Cancer
8%
Liver Cell Carcinoma
8%
Mortality Rate
8%
Antipsychotic
8%
microRNA 221
8%
Respiratory Tract Disease
8%
Synergism
8%
Chromosome Aberration
8%
P21 Activated Kinase
8%
Metastatic Colorectal Cancer
8%
Untranslated RNA
8%
Glioblastoma
8%
Kidney Disease
8%
Pancreas Adenocarcinoma
8%
Germ Cell Tumor
8%
microRNA 214
8%
Mouth Squamous Cell Carcinoma
8%
Glycoprotein Gp 130
8%
Collagenase 3
8%
Diabetes Mellitus
8%
Tumor Microenvironment
8%
Interleukin 11
8%
Argininosuccinate Synthase
8%
Ependymoma
8%
Arginine
8%
Oxaliplatin
8%
Transforming Growth Factor
8%
6 N Methyladenosine
8%
Renal Cell Carcinoma
8%
Western Blot
8%
Bone Morphogenetic Protein
8%
Typical Antipsychotic
8%
Recurrent Disease
7%
Breast Cancer
6%
Heart Muscle Fibrosis
6%
Synthetase
6%
Protein Kinase R
6%
